Back

Longitudinal trajectories of guideline-directed medical therapy and 12-month mortality in acute heart failure: insights from the KorHF-III Registry

28 August 2026 (09:15 - 10:00)
Organised by: Logo
Congress Presentation Part of: Acute heart failure: risk and prognosis Epidemiology, Prognosis, Outcome ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Mr Rao Faizan

Kyung Hee University, Yongin (Korea (Republic of))

5 More presentations in this session

Presentation thumbnail
Multisystem risk profiling at discharge identifies a high-risk phenotype in acute decompensated heart failure
Assistant Professor A. Borizanova-Petkova (Sofia, BG)
Abstract Slides Video
Presentation thumbnail
Prognostic impact of estimated appendicular skeletal muscle index in relation to CONUT score in acute decompensated heart failure patients with reduced and preserved left ventricular ejection fraction
Doctor T. Kondo (Osaka, JP)
Abstract Slides Video
Presentation thumbnail
Four-pillar era mortality prediction in acute decompensated heart failure: the ICARUS score
Doctor L. Echeverria (Floridablanca, CO)
Abstract Slides Video
Presentation thumbnail
Multiparametric risk stratification for inadequate natriuretic response to hypertonic saline supported diuretics in acute decompensated heart failure
Doctor G. Yilmaz (Ankara, TR)
Abstract Slides Video
Presentation thumbnail
Prognostic impact of right ventricular–vascular uncoupling in acute heart failure across the left ventricular ejection fraction spectrum: a meta-analysis of multivariable-adjusted data
Doctor F. Guz (Bucharest, RO)
Abstract Slides Video

Access the full session

Session thumbnail
Acute heart failure: risk and prognosis

The Event

Event poster

ESC Congress 2026

28 August 2026 09:15 CET
You may be interested in
thumbnail
Congress Presentation
Association of poor adherence to guideline-directed medical treatment with adverse events including fatal arrhythmia in heart failure with reduced ejection fraction: A nationwide cohort analysis
11 May 2026
thumbnail
Congress Presentation
High-dose guideline-directed medical therapy at discharge reduces mortality in hospitalized patients with heart failure with reduced ejection fraction: evidence from the HEROES study
1 September 2025
thumbnail
Congress Presentation
Rapid up-titration of guideline-directed medical therapy in real-world clinical practice: initial experience of a heart failure outpatient clinic
19 May 2025
thumbnail
Congress Presentation
Temporal trends and prognostic impact of comprehensive guideline-directed medical therapy in HFrEF: a 1-year follow-up from the KorHF III registry
28 August 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources